Breaking News Instant updates and real-time market news.

PNNT

PennantPark

$2.32 /

-0.105 (-4.34%)

08:03
04/06/20
04/06
08:03
04/06/20
08:03

PennantPark says well-positioned to confront COVID-19 downturn

PennantPark Investment announced that it issued an open letter to its stakeholders regarding a business update amid the COVID-19 pandemic. The company said, "We felt it important to provide an update on PennantPark Investment Corporation in light of the massive economic and capital markets disruptions caused by COVID-19. First and foremost, we hope that you are safe and healthy in these difficult times. Fortunately, our entire PennantPark team is safe and healthy and has been successfully working remotely from home for the past three weeks. Our contingency planning has functioned effectively and as intended. As a result, the transition of our entire team to remote work has been smooth, and we are currently fully capable of maintaining our normal functionality to complete our operational requirements. We have also taken several measures to maintain the strong culture that we cherish despite the distance. We have always believed in open and transparent communication with all of our stakeholders and remain committed to those principles today. While it is too early to quantify the impact of COVID-19 on PNNT, we want to take this opportunity to share certain observations as we navigate through these unprecedented circumstances. We have an experienced investment team that has managed through multiple economic cycles, including the Global Financial Crisis. Our principal focus has been on our existing portfolio. Because we believe in proactive communication, we have been in frequent dialogue with our portfolio companies' management teams and their sponsor owners over the last month. In addition, we have strong analytics around the portfolio, so that we can understand and assess the likely impacts of the ongoing disruption caused by COVID-19 on our portfolio companies, as well as their ability to withstand those likely impacts. We have built resilience into the PNNT portfolio through a disciplined, diversified investment strategy. The PNNT portfolio includes investments in 78 companies, representing 30 different industries. Our value-oriented investment philosophy focuses on preserving capital and ensuring that our investments have an appropriate return profile in relation to risk. We have positioned our portfolio away from direct exposure to areas of the economy that we believe, based on currently available information, are likely to be most impacted by the COVID-19 pandemic. In particular, we have generally avoided direct investments in more cyclical industries that have been hard hit by the spread of COVID-19, including restaurants, retail, apparel, and airlines. Nevertheless, there are some companies in our portfolio that have seen a significant drop in revenues during March given the impact of COVID-19, such as those in the events and gaming industries, and we know that others are likely to suffer declines as economic disruptions continue. As of December 31, 2019, gaming represented approximately 3.5% of the portfolio and its subsidiaries, across four investments. Fortunately, one of these investments was substantially refinanced in the last 10 days, and another portfolio company is undertaking a construction-phase project which provides it with interest reserves into mid-2021. Energy represents approximately 10% of the portfolio, across three names. RAM Energy Holdings LLC's operating performance on its oil and gas wells has been strong, and more than 60% of its production is hedged at over $50 per barrel through October 2022. Further on the positive side, many of our portfolio companies are in businesses such as government services, defense contracting, software/communications, and cybersecurity, which we believe, based on current circumstances, will be less impacted by COVID-19 and its associated economic disruptions. Our portfolio is also made more robust by our reasonable leverage ratios, with leverage through our security of approximately 4.7x as of December 31, 2019. Moreover, we have focused our lending activity on the U.S. middle market, which we believe represents a highly dynamic segment of the economy and benefits from terms, structures and yields that are more attractive to lenders than those of larger companies. PNNT has a strong capital structure with diversified funding sources and no near-term maturities, including a $475 million revolving credit facility maturing in 2024 with a syndicate of 14 banks; a separate $250 million revolving credit facility maturing in 2024; $134 million of SBA debentures maturing in 2026; and $86 million of unsecured notes maturing in 2024. We have been in consistent dialogue with our lenders since the beginning of the COVID-19 disruption and are thankful for their support. Based on all of these factors, we believe PNNT is well positioned to confront the COVID-19 downturn and to prosper when the economy eventually recovers. Our management team has sought to align interests closely with investors. As previously disclosed, since mid-February, officers, directors and employees have purchased over 200,000 additional shares of PNNT common stock."

PNNT PennantPark
$2.32 /

-0.105 (-4.34%)

10/29/19 JPMorgan
JPMorgan downgrades PennantPark to Underweight, trims target to $6
10/29/19 JPMorgan
PennantPark downgraded to Underweight from Neutral at JPMorgan
05/13/19 Ladenburg
PennantPark downgraded to Neutral from Buy at Ladenburg
05/03/19 Compass Point
PennantPark downgraded to Neutral from Buy at Compass Point

TODAY'S FREE FLY STORIES

Recommendations
Zimmer Biomet price target raised to $180 from $165 at JMP Securities » 06:17
01/27/21
01/27
06:17
01/27/21
06:17
ZBH

Zimmer Biomet

$158.18 /

-1.16 (-0.73%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$158.18 /

-1.16 (-0.73%)

ZBH Zimmer Biomet
$158.18 /

-1.16 (-0.73%)

01/25/21 BTIG
Zimmer Biomet price target raised to $173 from $160 at BTIG
01/08/21 Piper Sandler
Zimmer Biomet price target raised to $185 from $160 at Piper Sandler
01/06/21 Truist
Zimmer Biomet price target raised to $174 from $152 at Truist
01/04/21 Evercore ISI
Zimmer Biomet upgraded to Outperform from In Line at Evercore ISI
ZBH Zimmer Biomet
$158.18 /

-1.16 (-0.73%)

ZBH Zimmer Biomet
$158.18 /

-1.16 (-0.73%)

Downgrade
Burlington Stores downgraded to Neutral from Buy at Citi » 06:16
01/27/21
01/27
06:16
01/27/21
06:16
BURL

Burlington Stores

$251.14 /

-1.39 (-0.55%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$251.14 /

-1.39 (-0.55%)

BURL Burlington Stores
$251.14 /

-1.39 (-0.55%)

01/22/21 Loop Capital
Burlington Stores price target raised to $290 from $255 at Loop Capital
01/21/21 Deutsche Bank
Burlington Stores price target raised to $279 from $246 at Deutsche Bank
01/04/21 JPMorgan
Burlington Stores price target raised to $254 from $224 at JPMorgan
12/22/20 Wells Fargo
Burlington Stores price target raised to $265 from $250 at Wells Fargo
BURL Burlington Stores
$251.14 /

-1.39 (-0.55%)

BURL Burlington Stores
$251.14 /

-1.39 (-0.55%)

BURL Burlington Stores
$251.14 /

-1.39 (-0.55%)

Initiation
Fate Therapeutics assumed with a Neutral at H.C. Wainwright » 06:16
01/27/21
01/27
06:16
01/27/21
06:16
FATE

Fate Therapeutics

$89.07 /

-7.08 (-7.36%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FATE Fate Therapeutics
$89.07 /

-7.08 (-7.36%)

FATE Fate Therapeutics
$89.07 /

-7.08 (-7.36%)

01/25/21 BMO Capital
Fate Therapeutics price target raised to $88 from $57 at BMO Capital
01/19/21 Oppenheimer
Fate Therapeutics price target raised to $135 from $70 at Oppenheimer
01/15/21 Barclays
Fate Therapeutics price target raised to $130 from $110 at Barclays
12/21/20 Stifel
Fate Therapeutics price target raised to $118 from $79 at Stifel
FATE Fate Therapeutics
$89.07 /

-7.08 (-7.36%)

  • 06
    Jan
  • 09
    Jun
FATE Fate Therapeutics
$89.07 /

-7.08 (-7.36%)

Initiation
Visa reinitiated with an Outperform at Bernstein » 06:15
01/27/21
01/27
06:15
01/27/21
06:15
V

Visa

$202.01 /

+1.03 (+0.51%)

Bernstein analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

01/26/21 KeyBanc
Visa downgraded to Sector Weight from Overweight at KeyBanc
01/26/21 Bernstein
Visa reinstated with an Outperform at Bernstein
01/14/21 Deutsche Bank
Visa price target raised to $270 from $220 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst upgrades
V Visa
$202.01 /

+1.03 (+0.51%)

  • 13
    Oct
V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

V Visa
$202.01 /

+1.03 (+0.51%)

Downgrade
GasLog downgraded to In Line from Outperform at Evercore ISI » 06:14
01/27/21
01/27
06:14
01/27/21
06:14
GLOG

GasLog

$4.17 /

-0.375 (-8.25%)

Evercore ISI analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOG GasLog
$4.17 /

-0.375 (-8.25%)

GLOG GasLog
$4.17 /

-0.375 (-8.25%)

09/01/20 DNB Markets
GasLog upgraded to Buy from Hold at DNB Markets
06/23/20 Fearnley
GasLog downgraded to Hold from Buy at Fearnley
06/02/20 Pareto
GasLog downgraded to Sell from Hold at Pareto
03/31/20 Pareto
GasLog upgraded to Hold from Sell at Pareto
GLOG GasLog
$4.17 /

-0.375 (-8.25%)

Recommendations
Teleflex price target raised to $440 from $375 at JMP Securities » 06:14
01/27/21
01/27
06:14
01/27/21
06:14
TFX

Teleflex

$383.21 /

+0.84 (+0.22%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TFX Teleflex
$383.21 /

+0.84 (+0.22%)

TFX Teleflex
$383.21 /

+0.84 (+0.22%)

01/11/21 Wells Fargo
Teleflex price target raised to $455 from $425 at Wells Fargo
01/06/21 Needham
Teleflex price target raised to $445 from $406 at Needham
12/15/20 SVB Leerink
Teleflex price target raised to $450 from $415 at SVB Leerink
12/15/20 UBS
Teleflex price target raised to $455 from $435 at UBS
TFX Teleflex
$383.21 /

+0.84 (+0.22%)

Downgrade
Ulta Beauty downgraded to Neutral from Buy at Citi » 06:14
01/27/21
01/27
06:14
01/27/21
06:14
ULTA

Ulta Beauty

$295.77 /

+0.03 (+0.01%)

Citi analyst Kelly Crago…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

01/21/21 Wells Fargo
Ulta Beauty price target raised to $330 from $320 at Wells Fargo
01/11/21 Cleveland Research
Ulta Beauty Q4-to-date comps appear ahead of consensus, says Cleveland Research
12/17/20 DA Davidson
Ulta Beauty comp acceleration seen 'among the best', says DA Davidson
12/14/20 JPMorgan
Ulta Beauty added to Analyst Focus List at JPMorgan
ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

ULTA Ulta Beauty
$295.77 /

+0.03 (+0.01%)

Recommendations
Steven Madden price target raised to $35 from $29 at Citi » 06:13
01/27/21
01/27
06:13
01/27/21
06:13
SHOO

Steven Madden

/

+

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
/

+

SHOO Steven Madden
/

+

12/10/20 B. Riley Securities
Steven Madden price target raised to $40 from $34 at B. Riley Securities
12/09/20 Loop Capital
Steven Madden price target raised to $35 from $25 at Loop Capital
12/09/20 Susquehanna
Steven Madden price target raised to $41 from $30 at Susquehanna
12/08/20 Jefferies
Deckers Brands price target raised to $346 from $315 at Jefferies
SHOO Steven Madden
/

+

Upgrade
Texas Instruments upgraded to Buy from Hold at Summit Insights » 06:13
01/27/21
01/27
06:13
01/27/21
06:13
TXN

Texas Instruments

/

+

Summit Insights upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

01/26/21 Barclays
Texas Instruments price target raised to $155 from $140 at Barclays
01/21/21 Oppenheimer
Texas Instruments price target raised to $185 from $180 at Oppenheimer
01/21/21 Oppenheimer
Texas Instruments price target raised to $185 from $180 at Oppenheimer
12/17/20 Deutsche Bank
Texas Instruments price target raised to $150 from $145 at Deutsche Bank
TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

Recommendations
Levi Strauss price target raised to $25 from $19 at Citi » 06:12
01/27/21
01/27
06:12
01/27/21
06:12
LEVI

Levi Strauss

$21.35 /

+0.13 (+0.61%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

01/07/21 JPMorgan
Levi Strauss price target raised to $21 from $18 at JPMorgan
12/30/20 Guggenheim
Levi Strauss price target raised to $24 from $20 at Guggenheim
12/10/20
Fly Intel: Top five analyst upgrades
12/10/20 Goldman Sachs
Levi Strauss upgraded to Buy from Sell at Goldman Sachs
LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

LEVI Levi Strauss
$21.35 /

+0.13 (+0.61%)

Hot Stocks
Amdocs' Optima selected by Windtre in Italy for monetization platform » 06:12
01/27/21
01/27
06:12
01/27/21
06:12
DOX

Amdocs

$71.52 /

-0.09 (-0.13%)

Amdocs announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$71.52 /

-0.09 (-0.13%)

DOX Amdocs
$71.52 /

-0.09 (-0.13%)

11/11/20 JPMorgan
Amdocs upgraded to Overweight with $75 target at JPMorgan
11/11/20 JPMorgan
Amdocs upgraded to Overweight from Neutral at JPMorgan
02/05/20 Oppenheimer
Amdocs price target raised to $85 from $77 at Oppenheimer
DOX Amdocs
$71.52 /

-0.09 (-0.13%)

DOX Amdocs
$71.52 /

-0.09 (-0.13%)

Recommendations
Neuronetics price target raised to $23 from $15 at JMP Securities » 06:12
01/27/21
01/27
06:12
01/27/21
06:12
STIM

Neuronetics

$18.81 /

-0.79 (-4.03%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$18.81 /

-0.79 (-4.03%)

STIM Neuronetics
$18.81 /

-0.79 (-4.03%)

01/22/21 William Blair
Neuronetics upgraded to Outperform from Market Perform at William Blair
01/21/21 BTIG
Neuronetics price target raised to $21 from $14 at BTIG
01/21/21 Piper Sandler
Neuronetics price target raised to $27 from $20 at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
STIM Neuronetics
$18.81 /

-0.79 (-4.03%)

STIM Neuronetics
$18.81 /

-0.79 (-4.03%)

STIM Neuronetics
$18.81 /

-0.79 (-4.03%)

Recommendations
Integra LifeSciences price target raised to $80 from $65 at JMP Securities » 06:11
01/27/21
01/27
06:11
01/27/21
06:11
IART

Integra LifeSciences

$69.91 /

+0.52 (+0.75%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IART Integra LifeSciences
$69.91 /

+0.52 (+0.75%)

IART Integra LifeSciences
$69.91 /

+0.52 (+0.75%)

01/19/21 BTIG
Integra LifeSciences price target raised to $72 from $66 at BTIG
01/07/21 Credit Suisse
Integra LifeSciences price target raised to $73 from $60 at Credit Suisse
01/06/21 Truist
Integra LifeSciences price target raised to $70 from $60 at Truist
12/17/20 Oppenheimer
Integra LifeSciences price target raised to $72 from $64 at Oppenheimer
IART Integra LifeSciences
$69.91 /

+0.52 (+0.75%)

IART Integra LifeSciences
$69.91 /

+0.52 (+0.75%)

Periodicals
Ant Group plans sale of EyeVerify amid user data scrutiny, FT reports » 06:10
01/27/21
01/27
06:10
01/27/21
06:10
BABA

Alibaba

$265.91 /

+4.45 (+1.70%)

Ant Group plans to sell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$265.91 /

+4.45 (+1.70%)

BABA Alibaba
$265.91 /

+4.45 (+1.70%)

01/26/21 KeyBanc
Pinduoduo downgraded to Sector Weight at KeyBanc on balanced risk/reward
01/26/21 Deutsche Bank
Alibaba price target lowered to $319 from $360 at Deutsche Bank
01/25/21
Fly Intel: Top five analyst initiations
01/25/21 Bernstein
Alibaba initiated with a Market Perform at Bernstein
BABA Alibaba
$265.91 /

+4.45 (+1.70%)

BABA Alibaba
$265.91 /

+4.45 (+1.70%)

BABA Alibaba
$265.91 /

+4.45 (+1.70%)

BABA Alibaba
$265.91 /

+4.45 (+1.70%)

Upgrade
Himax upgraded to Buy from Neutral at Nomura » 06:10
01/27/21
01/27
06:10
01/27/21
06:10
HIMX

Himax

$9.75 /

+0.95 (+10.80%)

Nomura upgraded Himax to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMX Himax
$9.75 /

+0.95 (+10.80%)

11/30/20 Baird
Himax price target raised to $11 from $8 at Baird
05/08/20 Lake Street
Himax challenges not due to change in competitive position, says Lake Street
04/01/20 Lake Street
Lake Street confident Himax positioned to see continued momentum
03/25/20 Baird
Himax emerging from transition, re- initiated with an Outperform at Baird
HIMX Himax
$9.75 /

+0.95 (+10.80%)

HIMX Himax
$9.75 /

+0.95 (+10.80%)

HIMX Himax
$9.75 /

+0.95 (+10.80%)

Recommendations
Capri Holdings price target raised to $53 from $32 at Citi » 06:10
01/27/21
01/27
06:10
01/27/21
06:10
CPRI

Capri Holdings

$42.44 /

-0.79 (-1.83%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

01/21/21 Deutsche Bank
Capri Holdings upgraded to Buy from Hold at Deutsche Bank
01/21/21 Deutsche Bank
Capri Holdings upgraded to Buy from Hold at Deutsche Bank
01/07/21 JPMorgan
Capri Holdings price target raised to $43 from $34 at JPMorgan
01/07/21 Barclays
Capri Holdings upgraded to Overweight from Equal Weight at Barclays
CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

CPRI Capri Holdings
$42.44 /

-0.79 (-1.83%)

Downgrade
SunPower downgraded to Neutral from Overweight at Piper Sandler » 06:10
01/27/21
01/27
06:10
01/27/21
06:10
SPWR

SunPower

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
/

+

SPWR SunPower
/

+

01/20/21 JPMorgan
SunPower price target raised to $25 from $21 at JPMorgan
01/20/21 Credit Suisse
SunPower price target raised to $23 from $16 at Credit Suisse
01/19/21 Piper Sandler
SunPower price target raised to $35 from $22 at Piper Sandler
01/12/21
Fly Intel: Top five analyst initiations
SPWR SunPower
/

+

SPWR SunPower
/

+

SPWR SunPower
/

+

SPWR SunPower
/

+

Downgrade
Navigator Holdings downgraded to In Line from Outperform at Evercore ISI » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
NVGS

Navigator Holdings

/

+

Evercore ISI downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVGS Navigator Holdings
/

+

NVGS Navigator Holdings
/

+

Upgrade
Liberty Oilfield Services upgraded to Outperform from In Line at Evercore ISI » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
LBRT

Liberty Oilfield Services

/

+

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LBRT Liberty Oilfield Services
/

+

LBRT Liberty Oilfield Services
/

+

01/11/21 Wolfe Research
Liberty Oilfield Services downgraded to Underperform from Peer Perform at Wolfe Research
12/24/20 Piper Sandler
Liberty Oilfield Services price target raised to $8 from $7.50 at Piper Sandler
12/15/20 Citi
Liberty Oilfield Services price target raised to $12 from $7 at Citi
12/07/20
Liberty Oilfield Services cut to Equal Weight at Wells Fargo following run-up
LBRT Liberty Oilfield Services
/

+

  • 07
    Oct
LBRT Liberty Oilfield Services
/

+

Earnings
Southside Bancshares reports Q4 EPS 89c, consensus 64c » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
SBSI

Southside Bancshares

$32.92 /

-0.29 (-0.87%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBSI Southside Bancshares
$32.92 /

-0.29 (-0.87%)

SBSI Southside Bancshares
$32.92 /

-0.29 (-0.87%)

12/15/20 Truist
Truist raises price targets on select regional banks
SBSI Southside Bancshares
$32.92 /

-0.29 (-0.87%)

Upgrade
NexTier Oilfield upgraded to Outperform from In Line at Evercore ISI » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
NEX

NexTier Oilfield

/

+

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEX NexTier Oilfield
/

+

NEX NexTier Oilfield
/

+

12/24/20 Piper Sandler
NexTier Oilfield price target raised to $4.10 from $3.25 at Piper Sandler
12/15/20 Citi
NexTier Oilfield price target raised to $4 from $3 at Citi
10/13/20 BofA
BofA cuts Liberty Oilfield to Neutral, sees outperformance to NexTier reversing
10/13/20 BofA
NexTier Oilfield upgraded to Buy on completions recovery expectations at BofA
NEX NexTier Oilfield
/

+

Recommendations
Deckers Brands price target raised to $380 from $310 at Citi » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
DECK

Deckers Brands

/

+

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DECK Deckers Brands
/

+

DECK Deckers Brands
/

+

01/22/21 Williams Capital
Deckers Brands initiated with a Buy at Williams Trading
01/21/21 UBS
Deckers Brands price target raised to $400 from $388 at UBS
01/13/21 BTIG
Deckers Brands price target raised to $412 from $307 at BTIG
12/11/20 Raymond James
Deckers Brands initiated with a Market Perform at Raymond James
DECK Deckers Brands
/

+

DECK Deckers Brands
/

+

Downgrade
eGain downgraded to Hold from Buy at Berenberg » 06:09
01/27/21
01/27
06:09
01/27/21
06:09
EGAN

eGain

$11.81 /

-0.21 (-1.75%)

Berenberg analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGAN eGain
$11.81 /

-0.21 (-1.75%)

EGAN eGain
$11.81 /

-0.21 (-1.75%)

01/14/21 Oppenheimer
eGain downgraded to Perform at Oppenheimer on elevated execution risk
01/14/21 Oppenheimer
eGain downgraded to Perform from Outperform at Oppenheimer
10/20/20 Berenberg
eGain initiated with a Buy at Berenberg
10/14/20 Benchmark
eGain share price may be benefiting from M&A speculation, says Benchmark
EGAN eGain
$11.81 /

-0.21 (-1.75%)

EGAN eGain
$11.81 /

-0.21 (-1.75%)

Periodicals
Regulator thinks GameStop trading could be 'systemicallly wrong,' Barron's says » 06:08
01/27/21
01/27
06:08
01/27/21
06:08
GME

GameStop

$145.00 /

+68.19 (+88.78%)

William Galvin, the top…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$145.00 /

+68.19 (+88.78%)

GME GameStop
$145.00 /

+68.19 (+88.78%)

01/25/21 KeyBanc
Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc
01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 Telsey Advisory
GameStop continues surge despite double downgrade at Telsey Advisory
01/25/21 Telsey Advisory
GameStop downgraded to Underperform from Outperform at Telsey Advisory
GME GameStop
$145.00 /

+68.19 (+88.78%)

GME GameStop
$145.00 /

+68.19 (+88.78%)

GME GameStop
$145.00 /

+68.19 (+88.78%)

GME GameStop
$145.00 /

+68.19 (+88.78%)

Hot Stocks
Anthem sees FY21 operating cash flow greater than $5.7B » 06:07
01/27/21
01/27
06:07
01/27/21
06:07
ANTM

Anthem

$312.51 /

-2.83 (-0.90%)

For FY21: Investment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

01/26/21 Cowen
Anthem price target raised to $360 from $330 at Cowen
01/15/21 Jefferies
Anthem upgraded to Buy on more constructive commercial outlook at Jefferies
01/15/21 Jefferies
Anthem upgraded to Buy from Hold at Jefferies
01/13/21 Argus
Anthem price target raised to $380 from $300 at Argus
ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

ANTM Anthem
$312.51 /

-2.83 (-0.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.